Prognostic roles of dysregulated METTL3 protein expression in cancers and potential anticancer value by inhibiting METTL3 function
OncologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Fundamental & clinical pharmacology
- Publicado em
- 7 jun 2024
- Citações
- 5
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Prognostic roles of dysregulated METTL3 protein expression in cancers and potential anticancer value by inhibiting METTL3 function
Rong Zhao, Jiaping Chen, Yangwei Wang, Han Xiao, Peiyuan Mei, Wei Lin, Mingxin Diao, Shiwen He, Yongde Liao, Wangyang Meng
Descritores MeSH
- Methyltransferases
- Neoplasms
- Cell Proliferation
- Antineoplastic Agents
- Biomarkers, Tumor
- Gene Expression Regulation, Neoplastic
- Apoptosis
- Cell Line, Tumor
- RNA, Messenger
- Humans
Veja também
Estudos relacionados
- BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway
- Integrative meta-analysis and experimental validation reveal the oncogenic role of SACS and its therapeutic targeting potential in colorectal cancer
- Role of SNHGs in Adverse Prognostic Factors in Cervical Cancer: A Systematic Review
- The regulatory role of ZFAS1/miRNAs/mRNAs axis in cancer: a systematic review